Cargando…
The Therapeutic Mechanism of Schisandrol A and Its Metabolites on Pulmonary Fibrosis Based on Plasma Metabonomics and Network Analysis
BACKGROUND: Schisandrol A (Sch A) is the main active ingredient of Schisandra chinensis (Turcz.) Baill. Our previous study showed that Sch A has anti-pulmonary fibrosis (PF) activity, but its metabolic-related mechanisms of action are not clear. METHODS: Here, we explored the therapeutic mechanisms...
Autores principales: | Qiaolongbatu, Xijier, Zhao, Wenjuan, Huang, Xucong, Qian, Feng, Yang, Xinyi, Wu, Jiaqi, Ma, Cui, Qu, Han, Wang, Li, Fan, Guorong, Wu, Zhenghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939797/ https://www.ncbi.nlm.nih.gov/pubmed/36814892 http://dx.doi.org/10.2147/DDDT.S391503 |
Ejemplares similares
-
Exploring the components and mechanisms of Shen-qi-wang-mo granule in the treatment of retinal vein occlusion by UPLC-Triple TOF MS/MS and network pharmacology
por: Zhao, Yi, et al.
Publicado: (2023) -
The Role and Mechanism of Hyperoside against Depression-like Behavior in Mice via the NLRP1 Inflammasome
por: Song, Aoqi, et al.
Publicado: (2022) -
Metabonomics: Mining for Metabolites in Biofluids
Publicado: (2002) -
The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice
por: Ai, Yongqiang, et al.
Publicado: (2021) -
Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice
por: Ai, Yongqiang, et al.
Publicado: (2021)